ReviewMissouri medicine
Insomnia: A Current Review.
Review in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.
- Long-term use of dual orexin receptor antagonists for the treatment of insomnia: a systematic review and meta-analysis.Arquivos de neuro-psiquiatria · 2026Pooled it
- Cognitive behavioral therapy for insomnia in neurodegenerative disorders-targeting sleep disturbances in Alzheimer's and Parkinson's disease: a scoping review.Frontiers in psychology · 2025Pooled it
- Effect of JAK Inhibitors on Fatigue and Sleep Quality in Patients with Rheumatoid Arthritis: A Narrative Review.Journal of clinical medicine · 2026Review
- Insomnia as a Public Health Issue: Sociomedical Determinants in the Adult Population of Serbia.Medicina (Kaunas, Lithuania) · 2026Article
- Analysis of characteristics of hospitalized patients with chronic insomnia: a single-center retrospective study.Frontiers in psychiatry · 2026Article
- Primary Care Records and Population Prevalence of Chronic Insomnia: Do They Match?Healthcare (Basel, Switzerland) · 2025Article
- The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs.Molecules (Basel, Switzerland) · 2025Review
- COVID-19 Pandemic and Sleep Health in Polish Female Students.Journal of clinical medicine · 2025Article
- The change of MRI indexes of brain glymphatic function and sleep status before and after repeated transcranial magnetic stimulation in insomnia disorder patients.Frontiers in neuroscience · 2025Article
- Fatigue as a moderator in symptom networks of insomnia, anxiety, and depression: insights from moderated network analysis.Frontiers in psychiatry · 2025Article
- Article
- The Impact of Insomnia on Dementia Risk in Hypertensive Individuals.In vivo (Athens, Greece)Article
- The Association of Insomnia and the Subsequent Cerebrovascular Accident in the Hypertension Population.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insomnia is a prevalent sleep disorder with pervasive effects on quality of life. The deleterious effects of insomnia are largely preventable with appropriate therapeutic interventions. Pharmacotherapy should be initiated in patients with inadequate response to CBT-I and tailored to comorbidities. Referral to a sleep medicine specialist should be considered in patients with a suboptimal response.
Indexed as
Identifiers
38404423PMC10887463W4394766915What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.